BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8332959)

  • 1. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.
    Imura Y; Terashita Z; Nishikawa K
    Life Sci; 1986 Jul; 39(2):111-7. PubMed ID: 3741541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
    Imanishi N; Komuro Y; Morooka S
    Lipids; 1991 Dec; 26(12):1391-5. PubMed ID: 1819739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs.
    Kawamura M; Kitayoshi T; Terashita Z; Fujiwara S; Takatani M; Nishikawa K
    J Lipid Mediat Cell Signal; 1994 May; 9(3):255-65. PubMed ID: 7921785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activated platelets in endotoxin-induced DIC in rats.
    Ito T; Asai F; Oshima T; Kobayashi S
    Thromb Res; 1990 Aug; 59(4):735-47. PubMed ID: 2080492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
    Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor.
    Iwase M; Yokota M; Kitaichi K; Wang L; Takagi K; Nagasaka T; Izawa H; Hasegawa T
    Crit Care Med; 2001 Mar; 29(3):609-17. PubMed ID: 11373429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue.
    Nishiyama R; Nakamura S; Suzuki S; Baba S
    Transplantation; 1993 Jun; 55(6):1261-5. PubMed ID: 8516812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
    Ou MC; Kambayashi J; Kawasaki T; Uemura Y; Shinozaki K; Shiba E; Sakon M; Yukawa M; Mori T
    Thromb Res; 1994 Feb; 73(3-4):227-38. PubMed ID: 8191415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
    Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
    Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Res Exp Med (Berl); 1981; 179(3):223-8. PubMed ID: 7323452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats.
    Inoue Y; Kohno S; Miyazaki T; Yamaguchi K
    Tohoku J Exp Med; 1991 Mar; 163(3):175-85. PubMed ID: 2063402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.